Yasir Al-Wakeel
Director/Board Member at MAXCYTE, INC.
Net worth: 449 933 $ as of 31/03/2024
Network origin in Yasir Al-Wakeel first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment ManagersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors.
329
| Subsidiary | Investment Managers | 329 |
| Public Company | Biotechnology | 22 | |
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 16 | |
| Subsidiary | Biotechnology | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yasir Al-Wakeel via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Public Communications Contact | |
| LEGG MASON, INC. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| NOVAVAX, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| LUMINEX CORPORATION | Medical Specialties | Chief Executive Officer Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
JPMorgan Securities Plc
 JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets. | Financial Conglomerates | Analyst-Equity Analyst-Equity Market Strategist Sales & Marketing | |
| Boston University | College/University | Undergraduate Degree Graduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Director/Board Member | |
MdBio, Inc.
 MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| The University of Edinburgh | College/University | Graduate Degree Graduate Degree | |
| Indiana University | College/University | Doctorate Degree Doctorate Degree | |
| The Johns Hopkins University | College/University | Masters Business Admin Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| Williams College | College/University | Undergraduate Degree Undergraduate Degree | |
| IOMAI CORPORATION | Biotechnology | Chief Executive Officer Director/Board Member | |
Morgan Stanley & Co. International Plc
 Morgan Stanley & Co. International Plc Regional BanksFinance Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions. | Regional Banks | Analyst-Equity Analyst-Fixed Income | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| University of Lund | College/University | Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| Ghent University | College/University | Doctorate Degree Doctorate Degree | |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
 Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Joh. Berenberg, Gossler & Co. KG (United Kingdom) (Berenberg-UK) is the Great Britain-based broker/dealer division of Joh. Berenberg, Gossler & Co. KG, a multinational full-service investment bank in Germany. Headquartered in London, Berenberg-UK was founded in 2003 and provides trading and brokerage services to institutional and corporate clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The private company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
RBC Europe Ltd. (Broker)
 RBC Europe Ltd. (Broker) Investment Banks/BrokersFinance RBC Europe Ltd. is the Great Britain-based broker/dealer subsidiary of RBC Europe Ltd., itself a subsidiary of Royal Bank of Canada (TSE: RY) in Canada. Headquartered in London, the firm was founded in 1970 and provides a full spectrum of brokerage services specifically tailored for both retail and institutional investors. The firm is active in several markets, exchanges, and electronic trading platforms. | Investment Banks/Brokers | Analyst-Equity Sales & Marketing | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The private company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NatWest Markets Plc (Broker) | Investment Banks/Brokers | Analyst-Equity Market Strategist | |
Commerzbank AG (Broker)
 Commerzbank AG (Broker) Investment Banks/BrokersFinance Commerzbank AG (Broker) (Commerzbank-Broker) is the brokerage division of Commerzbank AG (ETR: CBK) in Germany. In 2009, following Commerzbank's acquisition of Dresdner Kleinwort the group created a Corporates & Markets platform which integrated the business of Dresdner Kleinwort GmbH-Investment Management. Headquartered in Frankfurt, Commerzbank-Broker provides trade solutions to multinational corporations, institutional investors, public entities, SMEs and private clients. They also offer risk management and structured financing solutions. | Investment Banks/Brokers | Analyst-Equity | |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Founder Consultant / Advisor | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Standard Chartered Bank (Broker) | Investment Banks/Brokers | Analyst-Equity | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member General Counsel | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Corporate Officer/Principal Director of Finance/CFO |
Statistics
International
| United States | 34 |
| United Kingdom | 9 |
| Sweden | 7 |
| Belgium | 2 |
| Germany | 2 |
Sectoral
| Consumer Services | 19 |
| Health Technology | 18 |
| Finance | 11 |
| Commercial Services | 5 |
| Health Services | 2 |
Operational
| Director/Board Member | 266 |
| Corporate Officer/Principal | 117 |
| Independent Dir/Board Member | 81 |
| Analyst-Equity | 66 |
| Chairman | 45 |
Most connected contacts
| Insiders | |
|---|---|
| Otello Stampacchia | 37 |
| Jacob Uno Stanley Gunterberg | 33 |
| Johannes G. C. P. Schikan | 22 |
| Julian Adams | 22 |
| Patrick Balthrop | 21 |
| John Martin | 20 |
| Jakob Loven | 19 |
| Sandra Gardiner | 19 |
| Rekha Hemrajani | 17 |
| Will Brooke | 16 |
| Richard Peters | 16 |
| J. Stark Thompson | 14 |
| Marianne de Backer | 14 |
| Douglas Swirsky | 14 |
| Roshawn Blunt | 14 |
- Stock Market
- Insiders
- Yasir Al-Wakeel
- Company connections